Literature DB >> 17889304

Piglets born from handmade cloning, an innovative cloning method without micromanipulation.

Y Du1, P M Kragh, Y Zhang, J Li, M Schmidt, I B Bøgh, X Zhang, S Purup, A L Jørgensen, A M Pedersen, K Villemoes, H Yang, L Bolund, G Vajta.   

Abstract

Porcine handmade cloning (HMC), a simplified alternative of micromanipulation based traditional cloning (TC) has been developed in multiple phases during the past years, but the final evidence of its biological value, births of piglets was missing. Here we report the first births of healthy piglets after transfer of blastocysts produced by HMC. As a cumulative effect of technical optimization, 64.3+/-2.3 (mean+/-S.E.M.) reconstructed embryos from 151.3+/-4.8 oocytes could be obtained after 3-4h manual work, including 1h pause between fusion and activation. About half (50.1+/-2.8%, n=16) of HMC reconstructed embryos developed to blastocysts with an average cell number of 77+/-3 (n=26) after 7 days in vitro culture (IVC). According to our knowledge, this is the highest in vitro developmental rate after porcine somatic cell nuclear transfer (SCNT). A total of 416 blastocysts from HMC, mixed with 150 blastocysts from TC using a cell line from a different breed were transferred surgically to nine synchronized recipients. Out of the four pregnancies (44.4%) two were lost, while two pregnancies went to term and litters of 3 and 10 piglets were delivered by Caesarean section, with live birth/transferred embryo efficiency of 17.2% (10/58) for HMC. Although more in vivo experiments are still needed to further stabilize the system, our data proves that porcine HMC may result in birth of healthy offspring. Future comparative examinations are required to prove the value of the new technique for large-scale application.

Entities:  

Mesh:

Year:  2007        PMID: 17889304     DOI: 10.1016/j.theriogenology.2007.07.021

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  32 in total

1.  High efficiency of BRCA1 knockout using rAAV-mediated gene targeting: developing a pig model for breast cancer.

Authors:  Yonglun Luo; Juan Li; Ying Liu; Lin Lin; Yutao Du; Shengting Li; Huanming Yang; Gábor Vajta; Henrik Callesen; Lars Bolund; Charlotte Brandt Sørensen
Journal:  Transgenic Res       Date:  2010-12-22       Impact factor: 2.788

Review 2.  Transgenic pigs as models for translational biomedical research.

Authors:  Bernhard Aigner; Simone Renner; Barbara Kessler; Nikolai Klymiuk; Mayuko Kurome; Annegret Wünsch; Eckhard Wolf
Journal:  J Mol Med (Berl)       Date:  2010-03-26       Impact factor: 4.599

3.  Establishment of a pig fibroblast-derived cell line for locus-directed transgene expression in cell cultures and blastocysts.

Authors:  Jannik E Jakobsen; Juan Li; Brian Moldt; Peter M Kragh; Henrik Callesen; Jens Michael Hertz; Lars Bolund; Arne Lund Jørgensen; Jacob Giehm Mikkelsen; Anders Lade Nielsen
Journal:  Mol Biol Rep       Date:  2010-03-25       Impact factor: 2.316

4.  Piglets cloned from induced pluripotent stem cells.

Authors:  Nana Fan; Jijun Chen; Zhouchun Shang; Hongwei Dou; Guangzhen Ji; Qingjian Zou; Lu Wu; Lixiazi He; Fang Wang; Kai Liu; Na Liu; Jianyong Han; Qi Zhou; Dengke Pan; Dongshan Yang; Bentian Zhao; Zhen Ouyang; Zhaoming Liu; Yu Zhao; Lin Lin; Chongming Zhong; Quanlei Wang; Shouqi Wang; Ying Xu; Jing Luan; Yu Liang; Zhenzhen Yang; Jing Li; Chunxia Lu; Gábor Vajta; Ziyi Li; Hongsheng Ouyang; Huayan Wang; Yong Wang; Yang Yang; Zhonghua Liu; Hong Wei; Zhidong Luan; Miguel A Esteban; Hongkui Deng; Huanming Yang; Duanqing Pei; Ning Li; Gang Pei; Lin Liu; Yutao Du; Lei Xiao; Liangxue Lai
Journal:  Cell Res       Date:  2012-12-18       Impact factor: 25.617

5.  Enhanced genome editing in mammalian cells with a modified dual-fluorescent surrogate system.

Authors:  Yan Zhou; Yong Liu; Dianna Hussmann; Peter Brøgger; Rasha Abdelkadhem Al-Saaidi; Shuang Tan; Lin Lin; Trine Skov Petersen; Guang Qian Zhou; Peter Bross; Lars Aagaard; Tino Klein; Sif Groth Rønn; Henrik Duelund Pedersen; Lars Bolund; Anders Lade Nielsen; Charlotte Brandt Sørensen; Yonglun Luo
Journal:  Cell Mol Life Sci       Date:  2016-01-11       Impact factor: 9.261

6.  Expression profile of developmentally important genes between hand-made cloned buffalo embryos produced from reprogramming of donor cell with oocytes extract and selection of recipient cytoplast through brilliant cresyl blue staining and in vitro fertilized embryos.

Authors:  Sadeesh Em; Meena Kataria; Balhara S; Ps Yadav
Journal:  J Assist Reprod Genet       Date:  2014-08-21       Impact factor: 3.412

7.  Handmade cloned transgenic piglets expressing the nematode fat-1 gene.

Authors:  Peng Zhang; Yidi Zhang; Hongwei Dou; Jingdong Yin; Yu Chen; Xinzhi Pang; Gabor Vajta; Lars Bolund; Yutao Du; Runlin Z Ma
Journal:  Cell Reprogram       Date:  2012-06       Impact factor: 1.987

8.  Overexpression of Porcine Beta-Defensin 2 Enhances Resistance to Actinobacillus pleuropneumoniae Infection in Pigs.

Authors:  Xi Yang; Yu-Ting Cheng; Mei-Fang Tan; Hua-Wei Zhang; Wan-Quan Liu; Geng Zou; Liang-Sheng Zhang; Chun-Yan Zhang; Si-Min Deng; Lei Yu; Xue-Ying Hu; Lu Li; Rui Zhou
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

9.  Hemizygous minipigs produced by random gene insertion and handmade cloning express the Alzheimer's disease-causing dominant mutation APPsw.

Authors:  Peter M Kragh; Anders Lade Nielsen; Juan Li; Yutao Du; Lin Lin; Mette Schmidt; Ingrid Brück Bøgh; Ida E Holm; Jannik E Jakobsen; Marianne G Johansen; Stig Purup; Lars Bolund; Gábor Vajta; Arne Lund Jørgensen
Journal:  Transgenic Res       Date:  2009-01-29       Impact factor: 2.788

10.  Factors Determining the Efficiency of Porcine Somatic Cell Nuclear Transfer: Data Analysis with Over 200,000 Reconstructed Embryos.

Authors:  Tianbin Liu; Hongwei Dou; Xi Xiang; Lin Li; Yong Li; Lin Lin; Xinzhi Pang; Yijie Zhang; Yu Chen; Jing Luan; Ying Xu; Zhenzhen Yang; Wenxian Yang; Huan Liu; Feida Li; Hui Wang; Huanming Yang; Lars Bolund; Gabor Vajta; Yutao Du
Journal:  Cell Reprogram       Date:  2015-12       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.